tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Bouchey, 4 are a BUY (100%).
Analyst David Bouchey, currently employed at AEGIS, carries an average stock price target met ratio of 16.67% that have a potential upside of 38.21% achieved within 367 days. Previously, David Bouchey worked at IFS.
David Bouchey’s has documented 8 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IINN, Inspira Technologies Oxy BHN Ltd at 24-Jan-2023.
Analyst best performing recommendations are on RMTI (ROCKWELL MEDICAL).
The best stock recommendation documented was for RMTI (ROCKWELL MEDICAL) at 10/19/2018. The price target of $11 was fulfilled within 734 days with a profit of $35.64 (76.42%) receiving and performance score of 1.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Aug-2022
$20
$13.37 (201.66%)
$2
21 days ago
(09-Jul-2026)
5/20 (25%)
$14.23 (246.62%)
235
Buy Since 05-Oct-2023
$5
$-1.63 (-24.59%)
$5
1 years 4 months 9 days ago
(21-Mar-2025)
3/3 (100%)
$3.65 (270.37%)
809
Buy Since 24-Jun-2019
$5
$3.95 (376.19%)
$121
1 years 8 months 16 days ago
(14-Nov-2024)
0/2 (0%)
$2.51 (100.80%)
Buy Since 24-Jun-2019
$110
6 years 5 months 3 days ago
(27-Feb-2020)
0/2 (0%)
$80.74 (275.94%)
Buy Since 14-Aug-2017
$121
$119.95 (11423.81%)
$11
7 years 1 months 11 days ago
(19-Jun-2019)
1/3 (33.33%)
$86.68 (252.56%)
734
What Year was the first public recommendation made by David Bouchey?
